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Abstract
In clinical situations where a diagnostic real-time PCR assay is not sensitive enough, leading to low or falsely negative
results, or where detection earlier in a disease progression would benefit the patient, an unbiased pre-amplification prior to
the real-time PCR could be beneficial. In Amp-PCR, an unbiased random Phi29 pre-amplification is combined with a specific
real-time PCR reaction. The two reactions are separated physically by a wax-layer (AmpliWaxH) and are run in sequel in the
same sealed tube. Amp-PCR can increase the specific PCR signal at least 100610
6-fold and make it possible to detect
positive samples normally under the detection limit of the specific real-time PCR. The risk of contamination is eliminated
and Amp-PCR could replace nested-PCR in situations where increased sensitivity is needed e.g. in routine PCR diagnostic
analysis. We show Amp-PCR to work on clinical samples containing circular and linear viral dsDNA genomes, but can work
well on DNA of any origin, both from non-cellular (virus) and cellular sources (bacteria, archae, eukaryotes).
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Introduction
Clinical laboratories around the world commonly uses specific
real-time PCR [1] for virus identification which is a rapid, sensitive
and specific method that is easy to perform, but has certain
limitations. The sensitivity and specificity of any given virus-specific
PCR vary depending on the robustness of the primers and the
genome variability or mutations in the primer-binding region of the
viralgenome,aswellasthetarget copynumber andtheefficiencyof
the reaction. Sometimes the PCR is not sensitive enough to detect
the causing agent in clinical situations with expected low viral load
or limited amount of sample, even if every measure has been taken
to design the most sensitive primers and probe from the sequence
known about a specific virus. Moreover, there appears to be an
inherent limitation to the PCR amplification of small amounts from
complex samples, known as the ‘‘Monte Carlo effect’’ [2]. Complex
samples, such as a clinical sample, containing a low viral copy
number close to the detection level of a PCR assay will experience
large variations in amplification and reduced reproducibility. These
limitations of the PCR technique can lead to low or falsely negative
results, which in turn may have consequences for the diagnosis and
treatment of patients. For example, in a multi-laboratory study of
Herpes Simplex virus PCR, which is a widely used and validated
PCR assay for cerebrospinal fluids (CSF),it wasfoundthat low-level
positives were often missed [3].
One current technique used to increase the sensitivity of a virus-
specific PCR-assay is nested-PCR [4], where two sets of primers
are used in two successive PCR-runs. The second set of primers,
are intended to amplify a target within the amplicon produced in
the first run by the first set of primers. However, the transfer of
PCR amplicons from the first to the second run, present a serious
risk of contamination in a routine laboratory, and the need for two
PCR reactions makes is more time consuming.
Random whole genome amplification (WGA) by isothermal
amplification using the Phi29 DNA polymerase has established
itself as an excellent alternative to random-PCR based amplifica-
tion. By isothermal multiple displacement amplification (MDA) in
the presence of random primers, Phi29 DNA polymerase allows
for uniform amplification across genomes with less than 3-fold bias
[5,6,7]. Furthermore, the Phi29 DNA polymerase has the highest
processivity rate reported, ,70 000 bases every time it binds [8]
and high fidelity with an error rate of only 1 in 10
6–10
7 bases [9].
Here we report about a method we call Amp-PCR that, in one
tube, combines random unbiased isothermal Phi29 amplification
with a virus-specific real-time PCR which increases the PCR signal
at least 100610
6-fold and makes it possible to detect amounts of
sample normally under the detection limit of a specific PCR. Since
both assays are performed after each other in the same closed tube
we eliminate the risk for contamination as no transfer of pre-
amplified sample is needed. We show this to work on clinical
samples containing both circular and linear double-stranded viral
DNA genomes, but the described method would work on any
DNA of any origin, as well as on cDNA of sizes 2000 bp or larger.
Materials and Methods
Ethics statement
This study was an improvement of the routine diagnostic assay
used at the Department of Virology, Statens Serum Institut,
Copenhagen, Denmark. A statement given by the Danish ethics
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Hovedstad), as a response to our enquiry, declare that according to
Danish law (Sundhedsloven) clinical samples received for routine
diagnostic analysis at Statens Serum Institut, Copenhagen,
Denmark (accredited and quality-controlled Danish National
reference diagnostic laboratory (ISO 17025); www.ssi.dk) can be
used for quality control, assay development and improvement of
routine techniques without ethics committee approval or written
consent from the patient. It was a blinded study with no patient
contact or patient information, only sample information.
Virus samples
Clinical samples used for this study were two JC polyomavirus
(JCV)-positive CSF samples, one human papillomavirus type 16
(HPV16)-positive cervical smear and one human herpes simplex-1
virus (HSV1)-positive swab sample. The JCV and the HPV16 are
both circular double-stranded DNA viruses of 5.1 and 7.9 kb,
respectively. HSV1 virus is a linear double-stranded DNA virus of
152 kb.
Pre-treatment and extraction of viral DNA in clinical
samples
Two hundred microliters of clinical sample was transferred to
an eppendorf tube and centrifuged at 17000 g for 10 minutes to
remove cell debris. The supernatant was then filtered through a
0.22 mm Ultrafree MC spin filter (Millipore) at 2000 g for 2
minutes and thereafter DNase treated (6 U DNaseI Amplification
grade, Invitrogen) for 1K hours at room temperature while
shaken in a Thermomixer (AH Diagnostics). The viral DNA was
extracted using the PureLink Viral RNA/DNA kit (Invitrogen),
without the addition of carrier RNA. The extracted viral DNA
was eluted with 20–30 ml DNase/RNase-free sterile water, and
stored at 220uC or immediately used.
Virus-specific real-time PCR
Real-time PCR master mixes specific for JCV, HPV16 or
HSV1 were prepared, using described primers and probe for JCV
[10,11] and in-house assays for HPV16 (primers HPV16-E6-12F
(59- CGA CCC AGA AAG TTA CCA CAG TT-39) and HPV16-
E6-12R (59- TGT TGC TTG CAG TAC ACA CAT TCT A-39),
and probe HPV16-E6-12P (59-FAM- CAC AGA GCT GCA AAC
AAC TAT ACA TGA TAT AAT-BHQ1-39)) and HSV1 (primers
HSV1-LPs (59-TGT GGT GTT TTT GGC ATC AT-39) and
HSV1-LPas (59- CCG ACA AGA ACC AAA AGG AA -39), and
probe HSV1-LPprobe (59-FAM- CAT GCG TGC CGT TGT
TCC CA-BHQ1-39)). Thirty microliters of virus-specific master
mix was prepared containing 15 ml of 2x QuantiTect Multiplex
PCR NoROX Master mix (contains HotStarTaq DNA polymer-
ase, Qiagen), 500 nM of each primer and 100 nM probe.
Repli-g amplification and virus-specific PCR combined in
Amp-PCR
Briefly, in Amp-PCR, a random unbiased isothermal Phi29
amplification (Repli-g Midi, Qiagen) reaction was combined with
a virus-specific real-time PCR and the two reactions physically
separated by a gem of AmpliWaxH melted in-between the two
layers (Figure 1A). In this way, the Repli-g reaction could be
performed first, at 30uC, while separated from the PCR master
mix. Furthermore, the HotStarTaq polymerase present in the
QuantiTect Multiplex PCR buffer in the PCR master mix is
inactive at 30uC. After completed Repli-g reaction, 15–30 minutes
incubation at 95uC inactivated the Phi29 DNA polymerase,
activated the HotStarTaq polymerase and melted the wax so that
the two reactions, the Repli-g and the PCR master mix, could be
mixed. Thereafter the PCR reaction was run for 45 cycles using
the amplified DNA as template.
In detail, thirty microliters of virus-specific master mix was put
in a 0.2 ml PCR-micro tube. One pellet of AmpliWaxH PCR Gem
50 (PE Applied Biosystems) was added on top of the PCR master
mix, the tube put in a cycler and incubated at 60uC for 5 minutes
to melt the wax followed by cooling at 37uC to solidify the wax on
top of the PCR master mix. Next, the random Phi29 amplification
reaction was prepared by making a 10 ml Repli-g Midi reaction
(1/5 of the normal reaction) according to manufacturer’s protocol
(Repli-g Midi kit, Qiagen). Briefly, 1 ml viral DNA was mixed with
1 ml of denaturation solution and incubated at room temperature
for 3 minutes. Two microliters of stop solution was added and the
sample mixed. Thereafter, 5.8 ml of Repli-g Midi reaction buffer
and 0.2 ml of Phi29 DNA polymerase was added and the sample
vortexed. After a short centrifugation, the Repli-g reaction was
added on top of the solidified AmpliWaxH, the tube closed and the
assay performed in a real-time Mx3005P-cycler (Stratagene). A
PCR control (called PCR only) was always included by adding 1 ml
viral DNA sample in 9 ml water on top of a wax-sealed master mix.
The following program was run: 30uC for 16 hours to run the
Repli-g reaction; 95uC for 15–30 minutes to inactivate the Phi29
DNA polymerase, to activate the Taq polymerase and to melt the
wax so that the Repli-g product was mixed with the PCR master
mix; followed by a 45 cycle-real-time PCR with 95uC for 15
seconds and 60uC for 1 minute.
Positive control for JCV
Standard curves to determine JCV copy number in clinical
samples were set up using the JCV Mad-1 pM1TC, kindly
provided by Dr Eugene Major at NINDS, NIH, Bethesda, USA
[11], at 10-fold dilutions starting at 1.8610
7 copies/ml (100 pg)
down to 1.8 copies/ml (10 ag). The 1.8 copies/ml standard solution
was freshly made before each experiment, by a 10-fold dilution of
the standard containing 18 copies/ml.
Results
In an attempt to further increase the sensitivity of virus-specific
real-time PCR, we established a method called Amp-PCR where a
random unbiased isothermal Phi29 amplification is combined with
a virus-specific real-time PCR, the two of them performed in
sequel in one tube (Figure 1A). To achieve this, we separated the
two reactions physically by melting a gem of AmpliWaxH in-
between the two layers, so that the PCR master mix was locked in
the bottom of the tube and separated from the Phi29 amplification
reaction that was placed on top of the AmpliWaxH-seal.
To test if the AmpliWaxH-seal would interfere with the PCR
reaction, we took 1 ml of purified JCV (,1800 copies/ml) from a
CSF clinical sample and added to a JCV-specific real-time PCR
master mix. A pellet of AmpliWaxH was melted on top and the
PCR performed (Figure 1B). We saw no difference in PCR-
performance with or without AmpliWaxH, and therefore conclud-
ed that the AmpliWaxH-seal did not interfere with the virus-
specific real-time PCR.
To find a good balance between the volumes of the Repli-g
reaction and the real-time PCR reaction in the Amp-PCR, we
tested different ratios (1:2, 1:3, 1:4 and 1:5) (data not shown). The
Repli-g reaction volume had to be large enough to allow for an
acceptable sample volume to be amplified and at the same time
not to be inhibitory for the real-time PCR. We tested 10 mlo f
Repli-g reaction which allowed for 1 ml of sample to be amplified.
This volume was combined with 4 different real-time PCR
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(1:5). Both 1:3 and 1:4 ratios worked well, while 1:2 seemed
inhibited and with 1:5 we felt that the volume of PCR reagents was
unnecessary large (data not shown). Based on this, for the further
analysis we decided to use the ratio of 1:3, with 10 ml of Repli-g
reaction and 30 ml of PCR reaction, and performed Amp-PCR by
combining 8 hours of Repli-g reaction with an AmpliWaxH-sealed
JCV-specific real-time PCR reaction (Figure 2). The sample used
was 50-fold diluted purified JCV (,36 copies/ml) from a CSF
clinical sample. In parallel, as a control, the sample in just water
was added on top of a wax-sealed PCR master mix (PCR only).
The Amp-PCR amplified the JCV 16.8610
6-fold (DCt=24) as
compared to the sample that only went through the PCR-step
(Figure 2). Furthermore, the negative control for the amplification
demonstrates that high-molecular weight DNA normally produced
in a Repli-g reaction in the absence of template (due to random
extension of primer-dimers (Repli-g Midi kit handbook, Qiagen)),
do not interfere with the specific real-time PCR reaction and is
negative in the assay.
To test the sensitivity of the Amp-PCR method, we used the
JCV Mad-1 pM1TC standard [11] at 180 and 1.8 copies/ml( 1f g
and 10 ag of DNA, respectively) in duplicate samples (Figure 3A–
B and Figure S1). We performed 16 hours of Repli-g reaction
combined with the JCV-specific PCR. Both duplicates of 180
copies/ml were detected in the PCR only (Figure 3A) and both
were strongly amplified after Amp-PCR (Figure 3B), with DCt=
,30 corresponding to a ,1000610
6-fold increase in signal. Both
duplicates showed a typical wave-shaped curve reported to be seen
when excess sample is over-saturating the PCR reaction [12]. A
multicomponent view of the wave-shaped curves confirmed typical
sigmoid curves that were identical in shape to non-saturated
samples, and were interpreted as JCV-specific results with Ct-
values of ,3-4 (Figure S1). The duplicate samples containing 1.8
copies/ml were clearly at the detection limit of the PCR reaction,
with Ct-values of 39 and 44 (Figure 3A). However, both duplicates
were strongly amplified (Ct=17 and Ct= ,4) (Figure 3B)
corresponding to between a 4610
6-fold (DCt =39217=22) and
1610
12-fold (DCt =4424=40) increase in signal, thereby
Figure 1. Description of the Amp-PCR method. In Amp-PCR a random pre-amplification step is combined with a specific real-time PCR and the
two reactions performed in sequel in the same closed tube. A physical barrier is created between the two reactions by the use of an AmpliWaxH-layer.
The Phi29-based pre-amplification (Repli-g) is performed first at 30uC, followed by 95uC to inactivate Phi29 plus activate the Taq enzyme and to melt
the wax, and finally the specific real-time PCR is performed. (A) Schematic picture of the Amp-PCR reaction in a 0.2 ml PCR-tube, including the Repli-g
reaction, the AmpliWaxH-seal and the specific real-time PCR reaction. (B) JCV-specific real-time PCR with or without AmpliWaxH, which do not
interfere with the JCV-specific PCR reaction. Negative control is water.
doi:10.1371/journal.pone.0015719.g001
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low copy number samples.
To investigate the reproducibility of the Amp-PCR assay, we
did 10 parallel reactions using the JCV Mad-1 pM1TC standard
[11] at 180 copies/ml (1 fg of DNA) (Table 1 and Figure S2). Ten
PCR only reactions showed a mean Ct-value of 34.260.5 and 10
Amp-PCR reactions a mean Ct-value of 3.960.7, demonstrating
good reproducibility. This corresponded to a 1300610
6-fold
increase in signal. The Amp-PCR reactions showed the wave-
shaped curves discussed above, but a multicomponent view
confirmed typical sigmoid curves with Ct-values of 3-5 (Figure S2).
To test the sensitivity of Amp-PCR on a clinical sample, we used
purified JCV DNA from a CSF clinical sample that was diluted
100-fold (,36 copies/ml) and 6400-fold (,0.6 copies/ml)
(Figure 3C and D). The sample containing 36 copies/ml was
detected in PCR only (Figure 3C) and strongly amplified after
16 hours Amp-PCR with a very strong JCV-signal (Ct= ,4),
showing a typical wave-shaped curve reported for over-saturated
PCR-reactions [12] and resulting in a 270610
6-fold increase in
signal (DCt=28). Neither of the duplicate samples containing 0.6
copies/ml gave a signal in PCR only (Figure 3C). However, one of
the duplicates was amplified in 16 hours Amp-PCR (Ct=27),
while the other one was not (Figure 3D) demonstrating that
samples under, or at, the detection limit of the real-time PCR
assay may get amplified and show a good signal in our Amp-PCR-
assay.
To show that this method could work equally well with other
viral DNA samples, we tested 16 hours Amp-PCR on two
additional clinical samples containing the DNA viruses HPV16
and HSV1, respectively (Figure 4). Amp-PCR on purified HPV16
from a cervical smear sample resulted in a 4300610
6-fold increase
in signal (DCt=32) compared to PCR only (Figure 4A). Amp-
PCR on purified HSV1 from a clinical swab sample, showing a
typical wave-shaped curve reported for over-saturated PCR-
reactions [12], resulted in a 134610
6-fold increase in signal
(DCt=27) compared to PCR only (Figure 4B). To further
demonstrate the specificity of the Amp-PCR, the HSV1-positive
sample used in Figure 4B was included as a negative clinical
control sample in a HPV16-specific Amp-PCR (Figure 4C). It was
negative both before (PCR only) and after amplification (Amp-
PCR), demonstrating no cross contamination and no un-specific
PCR results between specimens.
Discussion
A detection limit with maintained reproducibility of 10 copies
per PCR reaction, have been reported for a JCV-specific real-time
PCR [11]. With the additional use of a pre-amplification before
the specific PCR, a single copy of DNA should theoretically, be
detected with high reproducibility. In Figure 3B we show that 1.8
copy of JCV added to an Amp-PCR reaction was efficiently
amplified and detected. Furthermore, in Figure 3D we show that
diluted JCV containing 0.6 copy was detected by Amp-PCR but
not by PCR only.
Nested PCR is used to increase sensitivity in PCR, but at the
same time poses a severe risk of contamination in a clinical
laboratory since amplified material from the first PCR-reaction is
transferred to the second. Moreover, the need for two PCR
reactions makes it more time consuming. The Amp-PCR method
has eliminated this risk of cross-contamination since no transfer of
pre-amplified material is needed. Since the pre-amplification and
the specific PCR-reaction are run in the same tube, less time is
spent on pipetting, making the method less labour intense and can
be run overnight to fit into routine schedules. We show the Amp-
PCR method to increase the signal of a specific PCR several
million-fold (from 4610
6 to 1610
12) by increasing the amount of
sample going into the PCR-reaction. Furthermore, the Phi29
DNA polymerase generates long products suitable for efficient
PCR and is unbiased. Taken together, the Amp-PCR method
appears to be a reliable and reproducible method that is capable of
detecting amounts of sample normally under the detection limit of
a specific PCR.
It could also be possible to combine the Amp-PCR method with
a suitable reverse transcription (RT)-step, thereby enabling pre-
Figure 2. Amp-PCR on purified JCV from a clinical sample. Using purified viral JCV-DNA (,36 copies/ml) from a clinical CSF sample, 8 hours of
Amp-PCR was compared to PCR only. The DCt-value =24 demonstrating that Amp-PCR gives a strong amplification of the JVC material before the
specific PCR. Negative control for both amplification and PCR is water.
doi:10.1371/journal.pone.0015719.g002
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expression patterns or detect RNA viruses. This would help in the
monitoring of low RNA viral loads seen in situations as with anti-
retroviral treated patients or elite controllers during HIV
infections. Furthermore, the pre-amplification could also be
combined with a specific multiplex real-time PCR reaction,
instead of a single-plex reaction as used here.
When analysing clinical samples, the sample volume used for
purification of viral DNA, can easily be increased to more than
200 ml used here, thereby increasing the possibility of detection
Figure 3. Sensitivity of the Amp-PCR method. To test the sensitivity of 16 hours Amp-PCR, we used two JCV-standard solutions (containing 180
and 1.8 copies/ml, respectively) and two dilutions of a JCV DNA from a clinical sample (containing 36 and 0.6 copies/ml, respectively). Sixteen hours of
Repli-g reaction was followed by a JCV-specific real-time PCR reaction. (A) PCR only on duplicate samples of 180 and 1.8 copies/ml JCV-standards.
Negative control for the PCR is water. (B) Amp-PCR on duplicate samples of 180 and 1.8 copies/ml JCV-standards (showing typical wave-shaped curves
reported for over-saturated PCR-reactions). Negative control for the amplification is water. (C) PCR only on two diluted JCV DNA samples, containing
36 copies/ml and 0.6 copies/ml, respectively. Negative control for the PCR is water. (D) Amp-PCR on two diluted JCV DNA samples, containing 36
copies/ml (showing a typical wave-shaped curve reported for over-saturated PCR-reactions) and 0.6 copies/ml, respectively. Negative control for the
amplification is water.
doi:10.1371/journal.pone.0015719.g003
Table 1. Reproducibility of the Amp-PCR method.
Assay I II III IV V VI VII VIII IX X Mean Neg ctrl
Amp-PCR
a 43544344353 . 9 60.7 No Ct
PCR only
b 33.4 33.9 33.8 34.0 34.3 34.8 34.5 34.7 34.0 34.8 34.260.5 No Ct
aTen parallel Amp-PCR reactions using a JCV-standard containing 180 copies/ml.
bTen parallel PCR only-reactions using a JCV-standard containing 180 copies/ml.
doi:10.1371/journal.pone.0015719.t001
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that removal of contaminating human genomic DNA by DNase-
treatment during the purification step increased the sensitivity of
the assay, since the Phi29 DNA polymerase amplifies any DNA
present in the assay. The viral DNA is believed to be protected
from DNase-degradation inside the viral particle during this step
[13].
The Repli-g reaction contains random primers and Phi29 DNA
polymerase which by MDA amplifies the DNA present in the
sample. According to the Repli-g Midi protocol, the reaction
should be run for 16 hours to reach maximum yield of amplified
DNA (,40 mgi n5 0ml when starting with 10 ng, Qiagen). In our
case, a reaction time of 16 hours ensures that all random primers
are exhausted to reduce the risk of interference in the specific PCR
that follows. We found that samples with high copy number of
viral genomes exhausted the reagents in less than 16 hours. When
samples with low copy number are used, the full reaction time of
16 hours is needed for the reaction to run out of reagents or to
reach a point where the level of non-used random primers is low
enough to not interfere with the downstream real-time PCR.
High-copy samples generated an excess of products during the
Repli-g reaction, demonstrating the capacity of the Phi29
polymerase to produce large amounts of material, which resulted
in wave-shaped curves after real-time PCR (Figure 3B, 3D and 4).
If the pre-amplification had been run in a separate tube, as with
nested-PCR, one would only transfer minute amounts of the
Repli-g product to the PCR master mix to not over-saturate the
reaction. But since the reactions now appear in the same tube, all
generated Repli-g product is transferred to the PCR master mix
after the wax is melted. However, these curves are easily
distinguished as positive samples demonstrating typical sigmoid
curves with very low Ct-values (Figure S1 and S2). They are not
false positive and should not be interpreted as false negative, and
they only occur when high-copy number samples are analysed.
Figure 4. Testing Amp-PCR on other clinical samples. Amp-PCR was performed on a circular and a linear dsDNA virus purified from clinical
samples, combining 16 hours of Repli-g with virus-specific real-time PCR. (A) Amp-PCR on purified HPV16. Negative control is water. (B) Amp-PCR on
purified HSV1 (showing a typical wave-shaped curve reported for over-saturated PCR-reactions). Negative control is water. (C) HSV1-positive sample
used as a negative control in a HPV16-specific Amp-PCR.
doi:10.1371/journal.pone.0015719.g004
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the Amp-PCR can be over-saturated if being run for 16 h
(Figure 3D), while a shorter incubation time will generate normal
curves as seen in Figure 2. However, circular DNA, such as JCV,
has been reported to be efficiently amplified by Phi29 polymerase
through rolling circle amplification (RCA) [14] and would
probably generate over-saturated reactions at a lower copy-
number than seen for linear DNA samples. This assay was
primarily developed to solve a re-occurring diagnostic problem
with low-copy number samples.
The pre-amplification used here is a random isothermal MDA-
reaction performed by the Phi29 DNA polymerase together with
random hexamer primers, but other isothermal amplification-
reactions, e.g. primase-based WGA (pWGA; Rapisome, BioHelix
Corp.) could also be suitable. The Phi29 DNA polymerase does
not efficiently amplify DNA fragments of #2 kb in size [15]
(Repli-g Mini/Midi handbook, Qiagen), but works well on DNA
of any origin from both non-cellular (virus) and cellular sources
(bacteria, archae, eukaryotes), and on cDNA of sizes $2 kb. Since
the pre-amplification is not specific, any suitable DNA present in
the Repli-g-reaction will be amplified.
Thus, in clinical cases where the detection limit of a routine
real-time PCR assay is not sensitive enough, an unbiased pre-
amplification could be helpful. This could be when the virus is
present at very low amounts and where detection early in a disease
progression would benefit the patient with a better prognostic
outcome. This is true for cases of suspected progressive multifocal
leukoencephalopathy (PML) in the central nervous system in
immunosuppressed patients [16], where an early correct detection
of JCV viral DNA in the spinal fluid increases the chances for
survival [17,18]. Even if the real-time PCR used for a specific virus
is very sensitive, it is always a risk for false negative results when
analysing samples that are at the detection limit of the assay.
Again, an unbiased pre-amplification could be helpful to bring up
the copy number before the virus-specific real-time PCR assay. In
situations where the sample is precious and irretrievable, a pre-
amplification before a specific PCR would be helpful to reduce the
amount of sample needed for the analysis. This could be dried
blood samples on filter paper, or when working with ancient
samples, forensic samples [19] or single-cells from culture or cell-
sorting.
Supporting Information
Figure S1 Over-saturated samples in Figure 3 demon-
strate typical sigmoid curves. Multicomponent view of
over-saturated curves from Figure 3, demonstrating typical
sigmoid curves with a Ct-value of 3–4.
(PPTX)
Figure S2 Over-saturated samples in Table 1 demon-
strate typical sigmoid curves. Multicomponent view of
over-saturated curves used in Table 1, demonstrating typical
sigmoid curves with a Ct-value of 3–5. (A) dR view of results after
16 h Amp-PCR using a JCV standard containing 180 copies/ml.
(B) Multicomponent view of results after 16 h Amp-PCR using a
JCV standard containing 180 copies/ml. (C) dR view of results
after ‘PCR only’ using a JCV standard containing 180 copies/ml.
(D) Multicomponent view of results after ‘PCR only’ using a JCV
standard containing 180 copies/ml.
(PPTX)
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